Gabriella Verucchi
- Hepatology top 0.5%
- Hepatitis C virus research 52
- Hepatitis Viruses Studies and Epidemiology 10
- Liver Diseases and Immunity 5
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 37
- Hepatitis B Virus Studies 30
- Virology top 5%
- HIV Research and Treatment 6
- Emergency Medicine top 5%
- HIV-related health complications and treatments 8
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 11
- Co-authors
- Pietro AndreonéFabio ContiPaolo CaraceniMarco LenziS. BrillantiG. MazzellaF. BuonfiglioliFrancesco Giuseppe Foschi
- Cited by
- HepatologyEpidemiologyVirology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)Hepatology (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Gabriella Verucchi
85 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 1.5k
- Epidemiology 1.5k
- Virology 173
- Emergency Medicine 152
- Infectious Diseases 286
Countries citing papers authored by Gabriella Verucchi
This map shows the geographic impact of Gabriella Verucchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Verucchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Verucchi more than expected).
Fields of papers citing papers by Gabriella Verucchi
This network shows the impact of papers produced by Gabriella Verucchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Verucchi. The network helps show where Gabriella Verucchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gabriella Verucchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 6 | |
| 3 | Are hcv antibodies positive cirrhotic patients at lower risk of death as compared to cirrhotic of different etiologies when infected by COVID-19? | 2020 | 1 |
| 4 | 2020 | 7 | |
| 5 | 2018 | 47 | |
| 6 | What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group. | 2017 | 2 |
| 7 | 2017 | 62 | |
| 8 | 2017 | 5 | |
| 9 | 2016 | 6 | |
| 10 | 2015 | 8 | |
| 11 | 2015 | 16 | |
| 12 | 2014 | 99 | |
| 13 | 2010 | 8 | |
| 14 | 2009 | 1 | |
| 15 | 2008 | 187 | |
| 16 | 2007 | 5 | |
| 17 | 2001 | 7 | |
| 18 | 2001 | 2 | |
| 19 | 2001 | 27 | |
| 20 | 1989 | 2 |
About Gabriella Verucchi
Gabriella Verucchi is a scholar working on Hepatology, Epidemiology and Virology, having authored 86 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (52 papers), Liver Disease Diagnosis and Treatment (37 papers), Hepatitis B Virus Studies (30 papers), HIV/AIDS drug development and treatment (11 papers), Hepatitis Viruses Studies and Epidemiology (10 papers), HIV-related health complications and treatments (8 papers), HIV Research and Treatment (6 papers) and Liver Diseases and Immunity (5 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (1.5k citations) and Virology (173 citations). Gabriella Verucchi has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Pietro Andreoné, Fabio Conti, Paolo Caraceni, Marco Lenzi, S. Brillanti, G. Mazzella, F. Buonfiglioli, Francesco Giuseppe Foschi, Luigi Bolondi and Cristina Crespi. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.